87 related articles for article (PubMed ID: 26188731)
1. Glucocorticoids, calcitonin, and osteocalcin cannot differentiate between aggressive and nonaggressive central giant cell lesions of the jaws.
Martins AF; Souza PO; Rege IC; Morais MO; Mendonça EF
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Sep; 120(3):386-95. PubMed ID: 26188731
[TBL] [Abstract][Full Text] [Related]
2. Immunoexpression of calcitonin and glucocorticoid receptors in central giant cell lesions of the jaws.
Batista Severo ML; Lopes MLDS; Miguel MCDC; Germano AR; Nogueira RLM; Turatti E; Cavalcante RB; da Silveira ÉJD
J Oral Pathol Med; 2018 Oct; 47(9):907-913. PubMed ID: 30028524
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of RANK, GRalpha and CTR in central giant cell granuloma of the jaws.
Tobón-Arroyave SI; Franco-González LM; Isaza-Guzmán DM; Floréz-Moreno GA; Bravo-Vásquez T; Castañeda-Peláez DA; Vieco-Durán B
Oral Oncol; 2005 May; 41(5):480-8. PubMed ID: 15878752
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of alpha-smooth muscle actin and glucocorticoid and calcitonin receptors in central giant-cell lesions.
Maiz NN; de la Rosa-García E; Camacho ME
J Oral Pathol Med; 2016 Apr; 45(4):289-94. PubMed ID: 26467443
[TBL] [Abstract][Full Text] [Related]
5. CD34 staining density predicts giant cell tumor clinical behavior.
Susarla SM; August M; Dewsnup N; Faquin WC; Kaban LB; Dodson TB
J Oral Maxillofac Surg; 2009 May; 67(5):951-6. PubMed ID: 19375002
[TBL] [Abstract][Full Text] [Related]
6. Maxillofacial and axial/appendicular giant cell lesions: unique tumors or variants of the same disease?--A comparison of phenotypic, clinical, and radiographic characteristics.
Resnick CM; Margolis J; Susarla SM; Schwab JH; Hornicek FJ; Dodson TB; Kaban LB
J Oral Maxillofac Surg; 2010 Jan; 68(1):130-7. PubMed ID: 20006167
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid and calcitonin receptor expression in central giant cell lesions: implications for therapy.
Nogueira RL; Faria MH; Osterne RL; Cavalcante RB; Ribeiro RA; Rabenhorst SH
Int J Oral Maxillofac Surg; 2012 Aug; 41(8):994-1000. PubMed ID: 22365107
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of glucocorticoid and calcitonin receptors as a tool for selecting therapeutic approach in central giant cell granuloma of the jawbones.
Vered M; Buchner A; Dayan D
Int J Oral Maxillofac Surg; 2006 Aug; 35(8):756-60. PubMed ID: 16580179
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical evaluation of giant cell tumors of the jaws using CD34 density analysis.
Dewsnup NC; Susarla SM; Abulikemu M; Faquin WC; Kaban LB; August M
J Oral Maxillofac Surg; 2008 May; 66(5):928-33. PubMed ID: 18423282
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a subtype of primary osteoclastoma: extracellular calcium but not calcitonin inhibits aggressive HLA-DR-positive osteoclastoma possessing 'functional' calcitonin receptors.
Rathod H; Malcolm AJ; Gillespie JI; Berry V; Pooley J; Piggott NH; Datta HK
J Pathol; 1994 Dec; 174(4):293-9. PubMed ID: 7884591
[TBL] [Abstract][Full Text] [Related]
11. Giant cell lesions of the jaws: does the level of vascularity and angiogenesis correlate with behavior?
Peacock ZS; Jordan RC; Schmidt BL
J Oral Maxillofac Surg; 2012 Aug; 70(8):1860-6. PubMed ID: 22104131
[TBL] [Abstract][Full Text] [Related]
12. WWOX expression in giant cell lesions of the jaws.
Amaral FR; Diniz MG; Bernardes VF; Souza PE; Gomez RS; Gomes CC
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Aug; 116(2):210-3. PubMed ID: 23849374
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Genomic Profiling of Central Giant Cell Lesions Identifies Clinically Relevant Genomic Alterations.
Bezak B; Lehrke H; Elvin J; Gay L; Schembri-Wismayer D; Viozzi C
J Oral Maxillofac Surg; 2017 May; 75(5):955-961. PubMed ID: 27883876
[TBL] [Abstract][Full Text] [Related]
14. Do histologic criteria predict biologic behavior of giant cell lesions?
Peacock ZS; Resnick CM; Susarla SM; Faquin WC; Rosenberg AE; Nielsen GP; Schwab JH; Hornicek F; Ebb DH; Dodson TB; Kaban LB
J Oral Maxillofac Surg; 2012 Nov; 70(11):2573-80. PubMed ID: 22365980
[TBL] [Abstract][Full Text] [Related]
15. Central giant cell granulomas of the jaws: phenotype and proliferation-associated markers.
O'Malley M; Pogrel MA; Stewart JC; Silva RG; Regezi JA
J Oral Pathol Med; 1997 Apr; 26(4):159-63. PubMed ID: 9176789
[TBL] [Abstract][Full Text] [Related]
16. The highly prevalent H3F3A mutation in giant cell tumours of bone is not shared by sporadic central giant cell lesion of the jaws.
Gomes CC; Diniz MG; Amaral FR; Antonini Guimarães BV; Gomez RS
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Nov; 118(5):583-5. PubMed ID: 25442495
[TBL] [Abstract][Full Text] [Related]
17. Calcitonin nasal spray for treatment of central giant cell granuloma: clinical, radiological, and histological findings and immunohistochemical expression of calcitonin and glucocorticoid receptors.
Vered M; Shohat I; Buchner A; Dayan D; Taicher S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):226-39. PubMed ID: 17630098
[TBL] [Abstract][Full Text] [Related]
18. Osteoblast lineage properties in giant cell tumors of bone.
Murata A; Fujita T; Kawahara N; Tsuchiya H; Tomita K
J Orthop Sci; 2005 Nov; 10(6):581-8. PubMed ID: 16307183
[TBL] [Abstract][Full Text] [Related]
19. Central giant cell lesions of the jaws: a clinicopathologic study.
Chuong R; Kaban LB; Kozakewich H; Perez-Atayde A
J Oral Maxillofac Surg; 1986 Sep; 44(9):708-13. PubMed ID: 3462363
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 expression in central giant cell lesion of the jaws: an immunohistochemical study.
Nogueira RL; Faria MH; Osterne RL; Cavalcante RB; Ribeiro RA; Rabenhorst SH
J Mol Histol; 2012 Feb; 43(1):59-62. PubMed ID: 22042094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
